ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Graft survival"

  • 2020 American Transplant Congress

    CEACAM1 / ASK1 / p38 Signaling Axis Alleviates Peri-Transplant Liver Injury: From Mouse-to-Human

    H. Hirao1, K. Nakamura2, S. Kageyama1, T. Ito1, K. Kadono1, H. Kojima1, K. J. Dery1, S. Younan1, R. W. Busuttil1, F. M. Kaldas1, J. Kupiec-Weglinski1

    1UCLA, Los Angeles, CA, 2Kyoto University, Kyoto, Japan

    *Purpose: Although CEACAM1 (CM1; carcinoembryonic antigen-related cell adhesion molecule 1; CD66a) regulates hepatic metabolic homeostasis, its role in orthotopic liver transplantation (OLT) remains unknown. A…
  • 2020 American Transplant Congress

    Influence of Human Leukocyte Antigen Status and Gender of Positive Crossmatch Patients on Long-Term Survival Outcomes of Antibody Incompatible Renal Transplantation

    N. R. Macha1, A. Abimbola1, N. Khovanova2, D. Briggs3, N. Krishnan4

    1CIRAL, Coventry University, Coventry, United Kingdom, 2School of Engineering, University of Warwick, Warwickshire, United Kingdom, 3Director, Tissue Typing Lab, NHSBT, Birmingham, United Kingdom, 4Consultant Transplant Nephrologist and Visiting Professor, CIRAL, University Hospital Coventry & Warwickshire, Coventry, United Kingdom

    *Purpose: Human Leukocyte Antigen (HLA) sensitization is a significant obstacle which limits the use of renal transplantation, but it serves as a therapeutic option for…
  • 2020 American Transplant Congress

    Clinical Significance of Late Antibody-Mediated Rejection without Donor Specific Anti-hLA Antibodies

    J. Lee1, E. Kim1, S. Yang1, S. Kim1, B. Lim2, H. Choi3, B. Kim4, B. Kim4, M. Ju5, M. Kim1, S. Kim1, Y. Kim1, K. Huh1

    1Department of Transplantation Surgery, Severance Hospital, Seoul, Korea, Republic of, 2Department of Pathology, Yonsei University College of Medicine, Seoul, Korea, Republic of, 3Department of Internal Medicine, Gangnam Severance Hospital, Seoul, Korea, Republic of, 4Department of Internal Medicine, Severance Hospital, Seoul, Korea, Republic of, 5Department of Surgery, Gangnam Severance Hospital, Seoul, Korea, Republic of

    *Purpose: Late onset antibody-mediated rejection (AMR) is a leading cause of kidney allograft failure. Its diagnosis has been based on a combination of morphologic, immunohistologic…
  • 2020 American Transplant Congress

    Cyclophilin-D Inhibition Mitigates Cardiac Allograft Ischemia-Reperfusion Injury and Rejection

    A. Qamar1, P. McLeod2, J. Jiang2, X. Huang2, A. M. Jevnikar2, Z. Zhang2

    1Pathology & Laboratory Medicine, University of Western Ontario, London, ON, Canada, 2London Health Sciences Center, London, ON, Canada

    *Purpose: The clinical relevance of ischemia-reperfusion injury (IRI) in the context of organ transplantation is well-established. IRI is associated with various forms of programmed cell…
  • 2020 American Transplant Congress

    Effect of Cold Ischemia Time on Long-Term Graft Survival of Post-One Year Survivor Deceased Donor Kidney Transplant Recipients

    B. Murthy1, H. Nguyen2, A. Rana1, A. Awan1, C. Van Buren3, J. Goss1

    1Baylor College of Medicine, Houston, TX, 2University of Texas Medical Branch, Galveston, TX, 3University of Texas Houston Medical School, Houston, TX

    *Purpose: Prolonged cold ischemia time (CIT) is known to adversely affect short-term graft survival among renal allografts. However, its effect on long-term graft survival is…
  • 2020 American Transplant Congress

    Long Term Effect of Tacrolimus Conversion to Sirolimus with Prednisone-Free Regimen in Kidney Allograft Outcomes: A Dynamic Analysis of Graft Survival Using Joint Modeling

    S. H. Park1, B. Ho1, K. Guo1, L. Zhao2, V. Mas3, J. Leventhal4, L. Gallon1

    1Transplant Nephrology, Northwestern University, Chicago, IL, 2Preventive Medicine, Northwestern University, Chicago, IL, 3University of Tennesse, Memphis, TN, 4Transplant Surgery, Northwestern University, Chicago, IL

    *Purpose: Findings on long-term impacts of the mammalian target of rapamycin inhibitor inhibitors on kidney allograft are scarce and mixed. A joint modeling approach can…
  • 2020 American Transplant Congress

    Factors Associated with Renal Graft Loss in Simultaneous Kidney-Heart Transplant Recipients in the UNOS Cohort

    K. A. Agarwal1, H. Patel1, K. Almonte2, F. Cardarelli1, N. Agrawal1

    1Nephrology, Beth Israel Deaconess Medical Center, Boston, MA, 2Medicine, Mount Auburn Hospital, Cambridge, MA

    *Purpose: Simultaneous kidney and heart transplants (SKHT) are employed for patients with both end-stage heart failure and severely impaired kidney function. Renal outcomes in such…
  • 2020 American Transplant Congress

    Antibodies to Vascular Autoantigens Are Associated with Poor Long-Term Survival of Liver Re-Transplant

    Q. Xu1, V. C. McAlister2, S. Leckie2, A. A. House2, A. Zeevi1

    1Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, 2Multiorgan Transplant Program, London Health Sciences Centre, London, ON, Canada

    *Purpose: Autoantibodies, which may be generated in transplantation through the exposure of cryptic antigens, are reported to be detrimental for allograft survival. We have demonstrated…
  • 2020 American Transplant Congress

    Feasibility and Limitations of Desensitization Therapy in Highly Sensitized Pediatric ESRD Patients: A Single-Center Experience

    J. Steggerda1, H. Pizzo2, X. Zhang3, J. Garrison2, I. Kim1, M. Haas4, A. Vo1, S. Jordan1, D. Puliyanda2

    1Comprehensive Transplant Center, Cedars-Sinai Med Ctr, West Hollywood, CA, 2Pediatric Nephrology, Cedars-Sinai Med Ctr, West Hollywood, CA, 3HLA Laboratory, Cedars-Sinai Med Ctr, West Hollywood, CA, 4Renal Pathology, Cedars-Sinai Med Ctr, West Hollywood, CA

    *Purpose: There are a growing number of pediatric (peds) patients (pts) awaiting renal transplantation (tx) who are considered highly sensitized (HS). We report long-term outcomes…
  • 2020 American Transplant Congress

    Eplet Mismatch Imputed from HLA Serotype-Level Data Can Improve Risk Stratification for Kidney Allograft Loss

    A. Heinzel, R. Reindl-Schwaighofer, A. Kainz, K. Hu, R. Oberbauer

    Department of Medicine III - Division of Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria

    *Purpose: HLA-Epitope mismatch improves risk stratification following kidney transplantation. Based on population data, high resolution HLA types required for epitope prediction can be imputed based…
  • « Previous Page
  • 1
  • …
  • 29
  • 30
  • 31
  • 32
  • 33
  • …
  • 113
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences